Clinolamide

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 598933

CAS#: 3207-50-9

Description: Clinolamide is an antilipidemic drug.

Chemical Structure

img
Clinolamide
CAS# 3207-50-9
Instruction

Theoretical Analysis

MedKoo Cat#: 598933
Name: Clinolamide
CAS#: 3207-50-9
Chemical Formula: C24H43NO
Exact Mass: 361.33
Molecular Weight: 361.610
Elemental Analysis: C, 79.72; H, 11.99; N, 3.87; O, 4.42

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Clinolamide; Linolexamide; AC 32; Linoleic acid cyclohexylamide;

IUPAC/Chemical Name: (9Z,12Z)-N-cyclohexyloctadeca-9,12-dienamide

InChi Key: OFSPDNIHQQKLPZ-HZJYTTRNSA-N

InChi Code: InChI=1S/C24H43NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-24(26)25-23-20-17-16-18-21-23/h6-7,9-10,23H,2-5,8,11-22H2,1H3,(H,25,26)/b7-6-,10-9-

SMILES Code: CCCCC/C=C\C/C=C\CCCCCCCC(NC1CCCCC1)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 361.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Almukadi H, Wu H, Böhlke M, Kelley CJ, Maher TJ, Pino-Figueroa A. The macamide N-3-methoxybenzyl-linoleamide is a time-dependent fatty acid amide hydrolase (FAAH) inhibitor. Mol Neurobiol. 2013 Oct;48(2):333-9. doi: 10.1007/s12035-013-8499-2. Epub 2013 Jul 14. PubMed PMID: 23853040.

2: Huang JK, Jan CR. Linoleamide, a brain lipid that induces sleep, increases cytosolic Ca2+ levels in MDCK renal tubular cells. Life Sci. 2001 Jan 19;68(9):997-1004. PubMed PMID: 11212875.

3: Jenkins TC, Adams CS. The biohydrogenation of linoleamide in vitro and its effects on linoleic acid concentration in duodenal contents of sheep. J Anim Sci. 2002 Feb;80(2):533-40. PubMed PMID: 11881938.

4: Fukushima H, Aono S, Nakamura Y, Endo M, Imai T. The effect of N-(alpha-methylbenzyl) linoleamide on cholesterol metabolism in rats. J Atheroscler Res. 1969 Nov-Dec;10(3):403-14. PubMed PMID: 5364088.

5: Gong T, Zhang N, Kong KV, Goh D, Ying C, Auguste JL, Shum PP, Wei L, Humbert G, Yong KT, Olivo M. Rapid SERS monitoring of lipid-peroxidation-derived protein modifications in cells using photonic crystal fiber sensor. J Biophotonics. 2016 Jan;9(1-2):32-7. doi: 10.1002/jbio.201500168. Epub 2015 Sep 14. PubMed PMID: 26366883.

6: Piszcz J, Armitage EG, Ferrarini A, Rupérez FJ, Kulczynska A, Bolkun L, Kloczko J, Kretowski A, Urbanowicz A, Ciborowski M, Barbas C. To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients. Oncotarget. 2016 Apr 19;7(16):22324-38. doi: 10.18632/oncotarget.8078. PubMed PMID: 26988915; PubMed Central PMCID: PMC5008363.

7: Vamvakidès A. [Effect of GABA-linoleamide and glycine linoleamide on pentamethylenetetrazole convulsions]. J Pharmacol. 1986 Jul-Sep;17(3):323-7. French. PubMed PMID: 3025524.

8: Kritchevsky D, Tepper SA. Influence of N( -methylbenzyl)linoleamide upon cholesterol metabolism in rats. Arzneimittelforschung. 1971 Jul;21(7):1024-6. PubMed PMID: 5109487.

9: Vamvakidès A. [Synthesis and pharmacological study of glycine linoleamide]. Ann Pharm Fr. 1986;44(2):145-55. French. PubMed PMID: 3777786.

10: Abdulla YH, Adams CW. Cholesterol esterification in vitro with DL-N-(alpha-methylbenzyl)-(1-14C)linoleamide. Atherosclerosis. 1971 Jan-Feb;13(1):61-5. PubMed PMID: 5548455.

11: Vamvakidès A. [Effect of glutamic acid palmitamide or linoleamide on convulsions induced by pentetrazole]. Agressologie. 1989 Sep;30(8):469-71. French. PubMed PMID: 2558585.

12: Vamvakidès A. [Effect of glycine linoleamide on thermoregulation in mice and rats]. Agressologie. 1986 Feb;27(2):127-9. French. PubMed PMID: 3766887.

13: Dabur R, Mittal A. Detection and qualitative analysis of fatty acid amides in the urine of alcoholics using HPLC-QTOF-MS. Alcohol. 2016 May;52:71-78. doi: 10.1016/j.alcohol.2016.03.004. Epub 2016 Apr 2. PubMed PMID: 27139240.

14: Nakatani H, Fukushima H, Wakimura A, Endo M. N-cyclohexyl linoleamide: metabolism and cholesterol-lowering effect in rats. Science. 1966 Sep 9;153(3741):1267-9. PubMed PMID: 5918714.

15: Vamvakidès A. [Effect of GABA-linoleamide and glycine-linoleamide on catalepsy in the rat after chronic administration of reserpine]. Agressologie. 1986 Nov;27(10):835-7. French. PubMed PMID: 3028195.

16: Vamvakidès A. [Synthesis and pharmacological study of glutamic acid palmitamide and linoleamide]. Ann Pharm Fr. 1987;45(5):389-400. French. PubMed PMID: 2899415.

17: Vamvakidès A, Papadopoulou-Daïfoli Z. [Psychopharmacologic profile of a new product: GABA linoleamide (Gabalid)]. Agressologie. 1982 Oct;23(4):123-4. French. PubMed PMID: 7180983.

18: Gomi H, Nakatsuka I, Yoshitake A. 14C-labelling of a hypocholesterolemic agents, N-(alpha-methylbenzyl) linoleamide. Radioisotopes. 1980 Sep;29(9):443-5. PubMed PMID: 7221023.

19: Kritchevsky D, Sallata P, Tepper SA. Effect of N-cyclohexyl linoleamide on cholesterol metabolism in rats. Proc Soc Exp Biol Med. 1968 Jan;127(1):132-5. PubMed PMID: 5644631.

20: Kritchevsky D, Tepper SA. Linolexamide (N-cyclohexyl linoleamide) in experimental atherosclerosis in rabbits. J Atheroscler Res. 1967 Jul-Aug;7(4):527-30. PubMed PMID: 6050555.